The targeted clinical response is often termed, "initial control of the envenomation syndrome," and consists of arrest of the progression of local tissue venom effects, a clear trend toward improvement in any hematologic venom effects, and resolution of all systemic venom effects (excluding fasciculations or myokymia, which may be refractory to antivenom [ 7 , 11 ].
← all excerpts
Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.
1
—
—